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Abstract
Ileal lesions in Crohn’s disease (CD) patients are colonized by pathogenic adherent-invasive Escherichia coli (AIEC) able to
adhere to and invade intestinal epithelial cells (IEC), and to survive within macrophages. The interaction of AIEC with IEC
depends on bacterial factors mainly type 1 pili, flagella, and outer membrane proteins. In humans, proteases can act as host
defence mechanisms to counteract bacterial colonization. The protease meprin, composed of multimeric complexes of the
two subunits alpha and beta, is abundantly expressed in IECs. Decreased levels of this protease correlate with the severity of
the inflammation in patients with inflammatory bowel disease. The aim of the present study was to analyze the ability of
meprin to modulate the interaction of AIEC with IECs. In patients with ileal CD we observed decreased levels of meprins, in
particular that of meprin b. Dose-dependent inhibition of the abilities of AIEC strain LF82 to adhere to and invade intestinal
epithelial T84 cells was observed when bacteria were pre-treated with both exogenous meprin a and meprin b. Dose-
dependent proteolytic degradation of type 1 pili was observed in the presence of active meprins, but not with heat-
inactivated meprins, and pretreatment of AIEC bacteria with meprins impaired their ability to bind mannosylated host
receptors and led to decreased secretion of the pro-inflammatory cytokine IL-8 by infected T84 cells. Thus, decreased levels
of protective meprins as observed in CD patients may contribute to increased AIEC colonization.
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Introduction
Crohn’s disease (CD) and ulcerative colitis (UC) are the two
major forms of idiopathic inflammatory bowel disease (IBD), with
a combined prevalence of about 150–200 cases per 100,000 in
Western countries. They are multifactorial diseases, occurring in
individuals with genetic predisposition in whom an environmental
or infectious trigger causes an abnormal immune response [1,2].
Several lines of evidence suggest that bacteria play a role in the
onset and perpetuation of IBD [3]. Intestinal bacteria are essential
for the development of intestinal inflammation. In patients with
CD, post-surgical exposure to luminal contents of the terminal
ileum is associated with increased inflammation, and diversion of
the faecal stream is associated with improvement [4]. The
presence of intramucosal Escherichia coli or mucosa-associated E.
coli with invasive properties in CD patients has been reported in
independent studies performed in Europe and the United States
[5,6,7,8,9,10]. The phenotypic characterization of CD-associated
E. coli showed that they are highly adherent and invasive, and
accordingly they were termed adherent-invasive E. coli (AIEC)
[11]. They form a biofilm on the surface of the ileal mucosa owing
to abnormal expression of the specific host receptor CEACAM6
that recognizes the type 1 pili variant expressed by CD-associated
E. coli bacteria [12,13]. Flagella and outer membrane proteins
(OMPs) act in concert with type 1 pili to promote AIEC bacteria
adhesion to and invasion of intestinal epithelial cells and to induce
intestinal inflammation [13,14,15,16].
The intestinal mucosal surface is endowed with high proteolytic
activity involving numerous types of endo- and exoproteases,
thereby providing a broad substrate specificity. MEP1A has been
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identified as a genetic susceptibility factor for IBD [17,18]. It
encodes meprin a, an astacin-like metalloprotease synthesized as
zymogen, which is activated by tryptic proteolytic processing
[19,20,21]. Meprin a is secreted into the intestinal lumen or it is
retained at the brush border membrane in association with
transmembrane meprin b [22]. A variety of substrates that include
extracellular matrix proteins, growth factors, and cytokines
[23,24,25,26,27,28] are cleaved by meprins whose biological
function however is still poorly understood. The location and the
proteolytic activity of meprins are evidence of functions at the
interface of the host and the luminal environment. Meprin a
knock-out mice were more susceptible to DSS-induced experi-
mental colitis and underwent greater colon damage and
inflammation than wild-type mice [17,29]. Meprins may act as a
mucosal defence mechanism that protects the intestinal epithelium
against potential toxic peptides and also against enteric commensal
and pathogenic bacteria by modulating the interaction between
microbes and the host mucosa. The aims of the present study were
to investigate meprin mRNA expression in ileal biopsies of CD
patients since AIEC bacteria show a tropism for ileal colonization
in CD patients and to analyse the role of meprins in the interaction
of CD-associated E. coli and intestinal epithelial cells.
Results
Intestinal expression of meprins a and b
Meprin expression was analysed by quantitative RT-PCR. The
level of meprin a mRNA expression was not significantly lower in
Figure 1. Intestinal meprin a and meprin b mRNA. A and B, Mep1A (A) and Mep1B (B) mRNA levels were determined by TaqMan quantitative
real time PCR and are displayed as amounts relative to the intestinal epithelial marker villin-1. Healthy controls (hc) were compared with ulcerative
colitis (UC) and Crohn’s disease (CD) patients. CD patient biopsies were separated into groups with normal appearance or with macroscopic
inflammation, as determined by an experienced endoscopist. Statistics were performed using GraphPad Prism 5.0 Software, and P values were
calculated with the non-parametric Mann-Whitney test. C and D, Mep1A (C) and Mep1B (D) mRNA levels in C57Bl/6J mouse ileum and colon
uninfected or infected with AIEC LF82 bacteria. The effect of AIEC LF82 infection on meprin expression was determined in mouse ileum and colon by
quantitative real time PCR. Data are displayed as meprin amounts relative to the housekeeping TATA box binding protein (TBP) gene. Statistics were
performed using GraphPad Prism 5.0 Software, and P values were calculated with the one-way ANOVA test. Dot plots show individual samples with
relative mRNA (cDNA) amounts on a linear scale. Horizontal bars represent the median.
doi:10.1371/journal.pone.0021199.g001
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the ileal biopsies of UC or CD patients than that of healthy controls
(Fig. 1A). In contrast the level of meprin b mRNA expression was
significantly reduced in ileal biopsies of CD patients, compared to
that of healthy controls (Fig. 1B, P=0.0067 Mann-Whitney U
test). Interestingly, this was independent of macroscopic inflamma-
tion, as uninvolved ileal CD biopsies alone also showed significantly
less meprin b mRNA expression than did controls (Fig. 1B,
P=0.0387 after Bonferroni correction for multiple testing). Ileal
biopsies from UC patients showed equally high meprin b mRNA
expression as healthy controls. Of note, among non-IBD controls
two patients had diverticulitis and presented expression levels for
meprin a (1.6 and 2.4) and b (2.7 and 3.9) close to the median, and
one patient had pouchitis but the pouchitis-derived biopsy showed a
rather low level for meprin a (0.8) and almost average meprin b
expression (2.2).
Meprin expression was also analyzed in an adherent-
invasive E. coli (AIEC)-induced colitis model in C57BL/6J
mice. We observed that both meprin a and b were highly
expressed at the mRNA level in the ileum compared to the
colon (Fig. 1C and D). No significant modified expression of
both meprins was observed following AIEC reference strain
LF82 infection.
Exposure of AIEC bacteria to meprins a and b decreased
their ability to adhere to and to invade intestinal
epithelial cells
As endogenous meprins are synthesized in intestinal epithelial
cells as inactive zymogen, which has to be activated, to investigate
whether meprins can modulate the ability of AIEC bacteria to
interact with intestinal epithelial cells, AIEC bacteria were
pretreated with exogenous meprins a and b. The ability of the
AIEC LF82 to adhere to and to invade T84 cells was assessed
(Fig. 2). Quantitative adhesion assays showed that pretreatment of
AIEC LF82 bacteria with increased concentrations (from 0.1 to
100 mg/ml) of meprins a and b significantly (P,0.05) decreased in
a dose dependent manner the ability of bacteria to adhere to
differentiated T84 epithelial cells, compared to untreated bacteria
(Fig. 2A and 2D). Meprin-treated LF82 bacteria were also
significantly (P,0.05) impaired in their ability to invade
differentiated T84 cells, compared to untreated bacteria (Fig. 2B
and 2E). To ensure that the decreases in adhesion and invasion
levels of AIEC LF82 to cells were not due to bactericidal activity of
meprins, we checked that treatment with these proteases did not
affect bacterial viability (Fig. 2C and 2F). In addition, we
Figure 2. Meprins impair AIEC LF82 ability to adhere to and to invade differentiated intestinal epithelial cells. AIEC LF82 bacteria were
treated before infection with increased concentrations of exogenous meprins a and b (from 0.1 mg/ml to 100 mg/ml, see Materials and Methods
section). Differentiated T84 cells were infected at a MOI of 10 with untreated or meprin pretreated bacteria. A and D, the number of cell-associated
bacteria was determined after a 3 h infection period. B and E, the number of internalized bacteria was determined after a 3 h infection period
followed by gentamicin treatment for 1 h. Results are expressed as percentage of cell-associated (adherent + intracellular) (A and D), or intracellular (B
and E) bacteria relative to initial inoculum. C and F, effect of meprin treatment on AIEC bacteria viability. Equal amounts of bacteria were exposed or
not with a dose of 100 mg/ml of meprin a or b for 120 min. Thereafter, the number of viable bacteria was determined by plating on agar plate. Results
are expressed as colony forming units (CFU) per ml (C and F). Data are mean 6 SEM for at least three independent experiments. Student’s t-test,
* P,0.05.
doi:10.1371/journal.pone.0021199.g002
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observed that meprin-treated AIEC LF82 bacteria showed
significantly decreased adhesion to and invasion of undifferenti-
ated intestinal epithelial cells T84, Caco-2 and Intestine-407
(Fig. 3A and 3B). We also analyzed whether the effect of meprin
a and b on AIEC adhesion to and invasion of intestinal epithelial
cells was not limited to the AIEC strain LF82 and can be extended
to other AIEC strains and other enteric bacteria such as Salmonella
enterica serovar Typhimurium. Pretreatment of S. Typhimurium
strain LT2 with 10 mg/ml of meprin a or b did not induce any
significant decrease in either bacteria adhesion to or invasion of
T84 cells (Fig. 3C and 3D). In contrast, for all the other AIEC
strains tested (LF9, LF15 and LF31) a significant decreased ability
to adhere to and invade undifferentiated T84 cells was observed
when bacteria were treated with 10 mg/ml of both meprins
(Fig. 3C and D, P,0.05). Together, these results show that
meprins can modulate the interaction between AIEC bacteria and
intestinal epithelial cells. We further investigated which bacterial
components involved in the abilites of AIEC bacteria to adhere to
and invade intestinal epithelial cells were affected by meprin
treatment.
Meprins a and b do not induce proteolytic cleavage of
OMPs and flagellin
We have previously shown that outer membrane proteins
(OMPs), by binding to the Gp96 receptor and flagella, are
involved in the interaction of AIEC bacteria with intestinal
epithelial cells [14,16,30,31]. Meprins a and b at 100 mg/ml had
no proteolytic effect on LF82 OMPs as shown by Western blot
analysis using anti-OmpA, and OmpC/F antibodies and stan-
dardization against the inner membrane protein Lep (Fig. 4A).
Similarly, treatment of LF82 flagella with meprins a or b (100 mg/
ml) did not induce any proteolytic degradation of flagella as
observed by Western blot analysis of flagellin (Fig. 4B). Together
these results show that at the highest dose of meprins, the
decreased abilities of AIEC bacteria to adhere to and invade
intestinal epithelial cells were not due to degradation of LF82
OMPs or flagella.
Meprins a and b induce proteolytic cleavage of AIEC
LF82 type 1 pili
Experiments performed in vitro with cultured intestinal epithelial
cells, ex vivo with human isolated enterocytes from CD patients, or
in vivo using transgenic mice expressing the human CEACAM6
receptors showed that type 1 pili play a key role in the ability of
AIEC bacteria to adhere to and invade intestinal epithelial cells
[12,13,15]. We investigated whether the decrease in the abilities of
AIEC bacteria to adhere to and invade epithelial intestinal cells
observed after pretreatment of bacteria with meprin a or meprin b
could be the result of proteolytic degradation of type 1 pili by these
proteases. A dose-dependent proteolytic degradation of FimA, the
Figure 3. Effect of meprins on the ability of AIEC strains and Salmonella Typhimurium strain LT2 to adhere to and to invade
intestinal epithelial cells. Bacteria were pretreated with exogenous meprin a or meprin b at 10 mg/ml. A and B, undifferentiated Intestine-407
(I407), Caco-2 and T84 cells infected with AIEC LF82 at a MOI of 10. The number of associated (A) and internalized (B) bacteria was determined. Results
are expressed as the percentage of cell-associated (A) or intracellular bacteria (B) relative to initial inoculum. C and D, undifferentiated T84 cells were
infected at a MOI of 10 with Salmonella Typhimurium and AIEC strains LF82, LF9, LF15 and LF31. The number of associated (C) and internalized (D)
bacteria was determined. Results are expressed as the percentage of cell-associated (C) or intracellular bacteria (D) relative to untreated bacteria,
defined as 100% (bar, C and D). Data are mean 6 SEM for at least three independent experiments. Student’s t-test, * P,0.05.
doi:10.1371/journal.pone.0021199.g003
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major subunit of type 1 pili, was observed after treatment of AIEC
LF82 purified type 1 pili with meprins a and b (Fig. 5A).
Treatment of LF82 purified type 1 pili with 100 mg/ml of meprin
a or meprin b induced a strong decrease in the FimA band
observed on SDS-PAGE compared to untreated type 1 pili (89%
for meprin a and 72% for meprin b). We also analyzed the
proteolytic activity of meprins on type 1 pili present on the surface
of whole bacteria. The amount of FimA subunit relative to that of
the inner membrane protein Lep was determined by Western blot
after treatment of LF82 bacteria with active or heat-inactivated
meprin a or b. We observed 58% and 34% decreased amounts of
FimA after treatment of the bacteria with active meprins a and b,
respectively compared to those of untreated bacteria (Fig. 5B). In
contrast, when bacteria were treated with heat-inactivated meprins
the amount of FimA was unchanged. The degradation products of
purified AIEC LF82 type 1 pili following meprin treatment were
analyzed by mass spectrometry. Treatment of purified LF82 type 1
pili with 100 mg/ml of active meprins a and b, compared to heat
inactivated meprins, modified the mass spectrometry profile of
type 1 pili (Fig. 5C and 5D). A decrease in the intensity of the
base peak of spectrum corresponding to the protonated form ([M
+ H]+) of major analyte detected between 16259 and 16267 m/z
was observed after treatment with meprins. This was no longer
observed with heat inactivated meprins. The same observation was
made with the doubly protonated form ([M + 2H]2+) of this
analyte, detected between 8130 and 8134 m/z after treatment
with active meprins. Together, these results indicate that type 1 pili
are a major bacterial target of meprins and that the decreased
adhesion and invasion of AIEC bacteria to intestinal epithelial cells
after pretreatment of bacteria with exogenous meprins could be a
direct consequence of the proteolytic activity of these proteases
against type 1 pili.
Meprins affect mannose residue recognition mediated by
AIEC LF82 type 1 pili and the ability of AIEC bacteria to
induce IL-8 secretion
Adhesion of AIEC bacteria to cells that involved type 1 pili is
mediated by recognition between the FimH adhesin, located at the
tip of the pilus, and mannose residues on cellular receptors [32].
The ability of LF82 type 1 pili to bind D-mannose residues was
tested using a yeast aggregation assay. Pretreatment of bacteria
with meprin a and meprin b strongly reduced their ability to
induce yeast aggregation (Fig. 6A). The impaired recognition of
mannosylated receptor by AIEC bacteria could result from
meprin-mediated proteolysis of type 1 pili.
Pathogenic E. coli interaction with host cells generally induce
enhanced epithelial cell IL-8 secretion [33,34]. We quantified by
ELISA the levels of IL-8 secreted by T84 cells infected with AIEC
LF82 bacteria pretreated or not with 100 mg/ml of meprin a or b
(Fig. 6B). The amount of IL-8 secreted by T84 cells infected by
meprin a- or meprin b-treated bacteria was significantly lower
than that of cells infected with non-treated bacteria (24% and
28%, respectively, P,0.05) and was similar to the amount
observed with T84 cells infected by a non-piliated LF82 mutant
(LF82DfimA). To analyse whether bacterial components inducing
IL-8 secretion other than type 1 pili susceptible to meprin
degradation could exist, we performed assays with LF82DfimA
bacteria treated with meprins (Fig. 6B). IL-8 secretion by T84
cells remained similar following infection with LF82DfimA bacteria
treated or not with meprins. In addition, we did not also observe
any modified adhesion to T84 cells of LF82DfimA mutant treated
or not with meprins (Fig. 6C). Decreased IL-8 amounts as
measured by ELISA were not due to proteolytic degradation of IL-
8 by meprins (Fig. 6D). Thus, these results demonstrate that
meprins affect AIEC interaction with IEC, since degradation of
type 1 pili by meprins impaired recognition of D-mannose residues
by LF82 bacteria and subsequently decreased the ability of AIEC
LF82 to adhere to and invade IEC, resulting in decreased IL-8
secretion.
Discussion
According to the currently accepted hypothesis, both UC and
CD result from a dysregulated response of the intestinal immune
system to antigens of microbial origin or pathogenic bacteria in
genetically predisposed individuals. MEP1A has been identified as
a genetic susceptibility factor for IBD [17,18]. It encodes meprin
a, a metalloprotease highly expressed in the intestine. Meprin a is
secreted into the intestinal lumen or accumulates at the apical
brush border membrane of polarized epithelial cells retained by
meprin b. Thus any decrease in meprin a or b expression can lead
to similar defects in the host. In the present study, we analyzed
meprins a and b mRNA expression in ileal biopsies of CD patients
since AIEC are more frequently found in intestinal tissue samples
of CD patients, than in those of UC patients or healthy controls
and because AIEC bacteria show a tropism for ileal colonization.
Our real time PCR analysis with patient biopsies revealed that,
irrespective of macroscopic inflammation, the ileal mucosa of CD
patients had significantly weaker expression of meprin b than that
of non-IBD control biopsies. As meprin b is required to retain
meprin a, this may aggravate the deficit in meprin a/b secretion/
retention on the luminal side of the epithelial cell membrane. In
addition, we analyzed whether AIEC infection could modulate
meprin expression and observed no modified expression of either
meprin following AIEC LF82 mouse infection, indicating that the
exacerbation of colitis by infection did not interfere with meprin
expression.
Figure 4. Proteolytic activity of meprins a and b on AIEC LF82
outer membrane proteins and flagellin. Total protein extracts
from untreated or meprin-treated (100 mg/mL) whole bacteria
were immunoblotted for OmpA and OmpC/F (A) or Flagellin (B).
The inner membrane protein Lep was used as internal control.
Amounts of proteins were quantified by using Image J software.
Results are expressed as protein amount relative to Lep. Data are
mean 6 SEM for at least three independent experiments. Student’s
t-test, * P,0.05.
doi:10.1371/journal.pone.0021199.g004
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We speculated that defects in meprin expression on the surface
of the ileum could affect microbe-host interactions since proteases
could create a proteolytic environment which either kills bacteria
or degrades their virulence factors. This was well exemplified for
neutrophil elastase, which induces considerable degradation of E.
coli OmpA [35] or Pseudomonas aeruginosa flagellin [36], and for
lactoferrin, which cleaves IgA1 protease protein and Hap adhesin
of Haemophilus influenzae, [37]. We show that pretreatment of AIEC
bacteria with exogenous meprins a and b impaired the ability of
bacteria to adhere to and invade various differentiated or non
differentiated intestinal epithelial cells, indicating that any decrease
in meprin expression in the gut could result in increased AIEC
colonization. This indicated that meprins can participate in
modifications of the bacterial population associated with the gut
mucosa. Interestingly, no decreased adhesion or invasion was
observed with the enteroinvasive pathogen S. Typhimurium strain
LT2 treated with meprins, probably because these bacteria use a
type three secretion system to invade epithelial cells
We previously reported that AIEC colonization of the intestinal
mucosa is dependent on binding of type 1 pili to the glycosylated
CEACAM6 receptor, which is abnormally expressed by ileal
epithelial cells in CD patients [12]. We also previously reported
that flagella and outer membrane proteins (OMP) via outer
membrane vesicles are involved in the ability of AIEC bacteria to
adhere to and to invade cultured IEC in vitro [14,30,31]. We
investigated whether meprins target these virulence factors and
observed a proteolytic degradation of AIEC LF82 type 1 pili by
meprins a and b, but not of flagella and OMPs. This effect was
found with active meprins but no longer observed when bacteria
were treated with heat-inactivated meprins. The impaired ability
of meprin-treated bacteria to adhere to and invade various
intestinal epithelial cells could result from proteolytic degradation
of type 1 pili. Previous molecular dissections of virulence factor
expression in the AIEC reference strain LF82 suggested that these
bacteria are highly piliated under physiological conditions in the
gastrointestinal tract [16]. Any proteolytic degradation of type 1
pili could modify the behaviour of the AIEC bacteria within the
host, and any decrease in protease expression could therefore
increase AIEC colonization of the ileal mucosa.
AIEC infection of IECs induces the secretion of high amounts of
the pro-inflammatory cytokine IL-8, a potent chemoattractant for
neutrophils [7]. We observed that when AIEC LF82 bacteria were
treated by meprin a or b, IL-8 secretion by infected IECs was
significantly decreased. This effect was probably due to the
decrease in the ability of bacteria to adhere to and invade intestinal
epithelial cells as a consequence of proteolytic degradation of type
1 pili. These results are in accordance with our previous study
showing that the inflammation induced by AIEC infection of mice
expressing the human CEACAM6 was not observed when the
AIEC LF82 type 1 pili–negative mutant was used [13]. It can be
speculated that down-regulation of meprin expression observed in
CD patients leading to impaired meprin secretion/retention at the
epithelial brush border might favor not only colonization of the
intestinal mucosa by AIEC bacteria but also AIEC-induced
inflammation of the gut.
Materials and Methods
Patients and controls
CD: n= 27, mean age 41 years (25-88), 12 male and 15 female
patients. UC: n= 6, mean age 45 years (21–65), 2 male and 4
female patients. Controls: n = 18, mean age 55 years (38–74), 9
male and 9 female non-IBD individuals/patients. Biopsies were
collected during routine (patients) or screening (controls) endo-
scopic examination at the Gastroenterology unit, University
Hospital Bern, Bern, Switzerland. Biopsies were chosen solely
upon their location and macroscopic appearance, as judged by the
experienced endoscopist. CDAI and Mayo scores, although
determined routinely, were not used to stratify the cohort of
patients used in the present study. Informed written consent to use
biopsies for the present study was obtained from all patients, and
all procedures were approved by the ethical committee of the local
authorities of the Canton of Bern.
Mouse model and infection
Nine-week-old C57BL/6J (B6) mice (<19.5 g) were bred and
reared at the central animal facility of the medical faculty of the
University of Bern, Switzerland. They received DSS
(MW=36,000–50,000, MP Biomedicals, Illkirch, France) in
drinking water for 7 days with 3.5% (w/v) DSS for the first 3
days and 2.5% (w/v) DSS for the last 4 days. The mice were orally
challenged by 5 mg of streptomycin (Sigma) at day 3 and by 108
AIEC LF82 bacteria at day 4. They were sacrified at day 7 and the
ileum and colon were collected. Animal experiments were
approved by the local authorities of the canton of Bern and were
also in accordance with the Committee for Research and Ethical
Issues of the IASP.
Real-time mRNA quantification
Human ileal biopsies and mouse ileum and colon were placed in
RNAlater (Qiagen, Hombrechtikon, Switzerland). Samples were
kept for 24 h at 4uC and then at 220uC until RNA extraction.
RNAlater-preserved biopsies were homogenized in RLT buffer
(Qiagen) in a TissueLyzerTM (Qiagen) and RNA were isolated
using the mirVanaTM (mi)RNA Isolation Kit (Ambion, Applied
Biosystems, Rotkreuz, Switzerland). RNA quality was checked
with Agilent Bioanalyzer Nano Chips (Agilent Technologies,
Basel, Switzerland). One mg of RNA was reverse transcribed using
Promega’s ImProm-II Reverse Transcription System (Promega,
Mannheim, Germany) with random primers. Meprins a and b
mRNA were quantified from human samples using intron-
spanning TaqMan gene expression assays (Applied Biosystems)
and from mouse samples using Light Cycler 1.5 (Roche
Diagnostics) and SYBR green Taq ReadyMix (Sigma, St. Louis,
MO) with specific human and mouse oligonucleotides. Each
sample was run in duplicate. Results were normalized to the
Figure 5. Proteolytic activity of meprins a and b on AIEC LF82 type 1 pili. A, proteolytic effect of various concentrations (from 1 mg/ml to
100 mg/ml) of meprins on purified AIEC LF82 type 1 pili. Proteins were loaded on 15% polyacrylamid gel for SDS-PAGE and stained with Coomassie
brilliant blue. Results are expressed as FimA protein amount for meprin-treated type 1 pili relative to that of untreated type 1 pili. B, proteolytic effect
of meprins on type 1 pili expressed at the surface of whole AIEC LF82 bacteria. AIEC bacteria were untreated or treated with active or heat-inactivated
meprins at 100 mg/mL. Total proteins were immunoblotted with rabbit antiserum raised against purified type 1 pili and the inner membrane protein
Lep, as an internal control. Results are expressed as FimA amount relative to Lep. Amounts of proteins were quantified by using Image J software.
Data are mean 6 SEM for at least three independent experiments. Student’s t-test, * P,0.05. C and D, MALDI-TOF MS profile of purified AIEC LF82
type 1 pili treated with active or heat-inactivated meprin a or meprin b. Spectra were acquired in a mass spectrometer MALDI-TOF from LF82 type 1
pili treated with 100 mg/ml of meprin a (C) or with meprin b (D).
doi:10.1371/journal.pone.0021199.g005
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human epithelial marker villin gene or mouse TATA box binding
protein (TBP) housekeeping gene.
Bacterial strains
The four AIEC strains (AIEC reference strain LF82 and AIEC
strains LF9, LF15 and LF31) were isolated from patients with
Crohn’s disease [6,11]. The LF82-DfimA isogenic mutant does not
synthesize type 1 pili [38]. Salmonella Typhimurium strain LT2 was
purchased from ATCC (ATCC 700720). Bacteria were grown
routinely in Luria Bertani (LB) broth or on LB agar plates
overnight at 37uC.
Cell culture
The intestinal epithelial cell lines T84 (ATCC, CCL-248),
Intestine-407 (ATCC, CCL-6) and Caco-2 (ATCC, HTB-37) were
maintained in an atmosphere containing 5% CO2 at 37uC in the
culture medium recommended by ATCC. For infection assays,
undifferentiated T84, Intestine-407, and Caco-2 cells were seeded
in 24 well plates at a concentration of 4.105 per cm2. To obtain
differentiated T84 cells, cells were seeded onto Transwell filters at
8.105 cells/filter (5 mm pore size, 4.6 cm2; Costar, Corning Inc.)
and were grown for 21 days in an atmosphere containing 5% CO2
at 37uC.
Adhesion and Invasion Assays
Before infection, bacteria were pretreated for 120 min with
0.1 mg/ml to 100 mg/ml of exogenous meprin a or b in PBS (See
paragraph below). Meprins were then inactivated, and pretreated
bacteria were washed and used for infection. Cells were infected at a
multiplicity of infection (MOI) of 10 bacteria per cell. Adhesion and
invasion assays were performed as previously described [6]. For
adhesion assays, after 3 h of incubation period at 37uC, monolayers
were washed five times in phosphate buffer saline (PBS). To
determine the numbers of intracellular bacteria (Invasion assay), cell
culture medium containing 100 mg of gentamicin per ml was added
for 1 h to kill extracellular bacteria. The epithelial cells were then
lysed with 1% Triton X-100 (Sigma) in deionized water. Samples
were diluted and plated onto LB agar plates to determine the
number of colony-forming units (CFU).
Bacterial viability assay
Bacteria were pretreated with 100 mg/ml meprin a or meprin b
(expression and purification described previously [39,40]) at 37uC
for 120 min. Meprins were then inactivated and pretreated
bacteria were compared to untreated bacteria. Numbers of CFU
were determined from samples diluted and plated onto LB agar
plates.
Extraction of type 1 pili and total proteins
Type 1 pili were extracted as previously described [15,16].
Purified type 1 pili were subjected to HCl hydrolysis before SDS-
PAGE analysis because fimbriae are resistant to SDS disaggrega-
tion. After an overnight incubation at 37uC in LB broth, bacteria
were centrifuged and resuspended in SDS-PAGE loading buffer
(2% SDS, 50 mM Tris-HCl pH 6.8, 12.5% glycerol, 400 mM b-
mercaptoethanol and 0.01% Bromophenol Blue).
Treatment of whole bacteria, purified bacterial surface
components and recombinant human IL-8 with meprins
Whole bacteria were pretreated for 120 min with exogenous
meprin a or b (from 0.1 mg/ml to 100 mg/ml) in PBS. PBS
supplemented with 4 mM EDTA pH 7.4, was then added (20:1)
in order to inactivate meprin activity. The same protocol was used
for bacteria in the absence of meprin or in presence of 100
mg/ml of meprin a and b inactivated at 100uC for 15 min.
Bacteria were then washed twice in PBS by centrifugation and
resuspended in PBS for infection or in SDS-PAGE loading buffer
for Western-blotting.
Figure 6. Meprin treatment affect mannose residue recognition
by AIEC and AIEC-induced IL-8 secretion by T84 cells. A, ability
of type 1 pili to bind D-mannose residues as determined by a yeast
aggregation test. AIEC LF82 bacteria were treated with 100 mg/ml of
meprin a or b at 37uC for 120 min. A fixed amount of inactivated yeast
cells (Saccharomyces cerevisiae) suspension and decreasing concentra-
tions of treated and untreated bacteria were mixed, and the loss of the
ability to form homogenous aggregation was used as the read-out for
impaired type 1 pili-yeast interaction. B, Amount of IL-8 secreted by
uninfected or AIEC LF82- or type 1 pili negative mutant LF82-DfimA-
infected T84 cells, at 24 h post-infection. AIEC LF82 and LF82-DfimA
bacteria were treated with 100 mg/ml of meprins. Il-8 secretion was
determined by ELISA. Data are expressed as fold increase in the amount
of secreted IL-8 6 SEM by T84 cells infected with untreated or treated
bacteria relative to non infected cells. Student’s t-test, * P,0.05 for
comparison between IL-8 secretion induced by untreated versus
meprin-treated AIEC LF82 or LF82-DfimA bacteria. C, LF82-DfimA
bacteria were pretreated with exogenous meprin a or meprin b at
100 mg/ml and undifferentiated T84 cells were infected at a MOI of 10.
The number of associated bacteria was determined. Results are
expressed as the percentage of cell-associated bacteria pretreated with
exogenous meprins relative to untreated bacteria, defined as 100%.D,
effect of meprins on recombinant human IL-8. Recombinant human IL-8
(110 ng/ml) was treated with meprin a or b (100 mg/ml), electroblotted
and detected with mouse anti-human IL-8.
doi:10.1371/journal.pone.0021199.g006
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Purified type 1 pili were treated with increasing concentrations
(1 to 100 mg/ml) of meprin a and b, at 37uC for 120 min and
subjected to SDS-PAGE and mass spectrum analysis. In addition,
purified type 1 were also treated with 100 mg/ml of meprin a and
b inactivated at 100uC for 15 min.
Recombinant human IL-8 (110 ng/ml, R&D systems) was
treated with 100 mg/ml of meprin a or b at 37uC for 120 min
and was resuspended in SDS-PAGE loading buffer for
Western-blotting.
Western blotting
Purified bacterial surface components or total proteins were
subjected to SDS-PAGE on 12-17% gels. Protein concentrations
were determined by Bradford assay and the gels were stained for
protein with Coomassie brilliant blue. Western immunoblotting
was performed according to the procedure of Towbin [41].
Proteins were electroblotted onto nitrocellulose membranes
(Amersham International), and the membranes were immuno-
blotted for type 1 pili (rabbit antiserum raised against purified type
1 pilus preparations, diluted 1:1,000), Lep (rabbit anti-Lep, diluted
1:1,000), OmpA (rabbit anti-OmpA, diluted 1:1,00), OmpC/F
(rabbit anti-OmpC/F, diluted 1:1,000), flagellin (rabbit anti-H1,
diluted 1:500) and IL-8 (mouse anti-human; diluted 1/250; R & D
Systems). Immunoreactants were detected using horseradish
peroxidase-conjugated anti-rabbit or anti-mouse immunoglobulin
G antibody, ECL reagents (Amersham Biosciences) and autora-
diography. Image J software was use to estimate protein quantity.
Yeast cell aggregation assay
Bacteria were washed and resuspended to an optical density of
0.1 at 620 nm in PBS and treated or not with 100 mg/ml of
meprin a and meprin b at 37uC for 120 min. Equal volumes of
fixed commercial baker’s yeast cell (Saccharomyces cerevisiae)
suspension (10 mg dry weight/ml) in PBS and decreasing
concentrations of E. coli suspension were used, and aggregation
was monitored visually.
Mass spectrum analysis
Mass spectra were acquired by a mass spectrometer-DE PRO
(Applied Biosystems, Cortaboeuf) in positive ionization, linear
MODE. Briefly, 1 ml of type 1 pili was mixed on the MALDI plate
with 1 mL of Sinapinic acid matrix, using the standard dried-drop
method. Spectra were then generated in the mass-to-charge ratio
(m/z) range of 4,000 m/z to 20,000 m/z. Each spectrum was
calibrated by calibrant protein mixture (C110, LaserBiolabs,
Antibes, France).
Enzyme-linked immunosorbent assay (ELISA)
The amount of Il-8 released in the culture supernatant was
determined by ELISA (R&D systems). Cytokine concentrations
were assessed according to the manufacturer’s instructions.
Statistical Analysis
Data generated from adhesion and invasion assays or ELISA
were analysed by Student’s t-test. All experiments were performed
at least three times. A P-value #0.05 was considered statistically
significant. Data are expressed as the mean 6 SEM. Statistical
analysis of data generated from RT-PCR with human biopsies and
with mouse colon and ileum was performed using GraphPad
Prism 5.0 Software. For data generated from RT-PCR with
human biopsies, overall differences between groups were estimated
with the Kruskall Wallis test and P values were calculated with
planned posteriori tests using the non-parametric Mann-Whitney
U test. P-values as indicated in figure 1B were further corrected for
multiple testing by Bonferroni correction for final statements in
results and discussion. For data generated from RT-PCR with
mouse ileum and colon, overall differences between groups were
estimated with one-way ANOVA.
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